Trial Profile
A phase 3 trial of arformoterol in patients with chronic obstructive pulmonary disease (COPD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Arformoterol (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.